BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16026544)

  • 1. CBP sensitizes v-myb-transformed monoblasts to differentiation inducers.
    Smardová J; Nemajerová A; Navrátilová J; Jurdic P; Smarda J
    Differentiation; 2005 Jun; 73(5):222-32. PubMed ID: 16026544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts.
    Ondrousková E; Povolná K; Vána P; Benes P; Konecná H; Zdráhal Z; Smarda J
    Leuk Res; 2007 Feb; 31(2):221-9. PubMed ID: 16930693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells.
    Nemajerová A; Smarda J; Jurdic P; Kubala L; Soucek K; Smardová J
    J Hematother Stem Cell Res; 2003 Apr; 12(2):225-35. PubMed ID: 12804181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of RARalpha and RXRalpha proteins on growth, viability, and differentiation of v-myb-transformed monoblasts.
    Vodicka P; Sevcíková S; Smardová J; Soucek K; Smarda J
    Blood Cells Mol Dis; 2000 Aug; 26(4):395-406. PubMed ID: 11042040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts.
    Navrátilová J; Horváth V; Kozubík A; Lojek A; Lipsick J; Smarda J
    Differentiation; 2007 Sep; 75(7):592-604. PubMed ID: 17309603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts.
    Sevcíková S; Soucek K; Kubala L; Bryja V; Smarda J
    Cell Mol Life Sci; 2002 Oct; 59(10):1690-705. PubMed ID: 12475180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
    Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
    EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP.
    Takahashi T; Suwabe N; Dai P; Yamamoto M; Ishii S; Nakano T
    Oncogene; 2000 Jan; 19(1):134-40. PubMed ID: 10644988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells.
    Knopfova L; Smarda J
    Neoplasma; 2008; 55(4):286-93. PubMed ID: 18505338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid.
    Benes P; Macecková V; Zatloukalová J; Kovárová L; Smardová J; Smarda J
    Leuk Res; 2007 Oct; 31(10):1421-31. PubMed ID: 17624428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid X receptor suppresses transformation by the v-myb oncogene.
    Smarda J; Zemanová K; Bryja J; Smardová J; Kozubík A; Hofmanová J; Nemajerová A; Sevcíková S; Kohoutek J; Vodicka P
    J Leukoc Biol; 1999 Dec; 66(6):1039-48. PubMed ID: 10614788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifunctional role of the co-activator CBP in transcriptional regulation.
    Goldman PS; Tran VK; Goodman RH
    Recent Prog Horm Res; 1997; 52():103-19; discussion 119-20. PubMed ID: 9238849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v-Myb represses the transcription of Ets-2.
    Wang DM; Sevcikova S; Wen H; Roberts S; Lipsick JS
    Oncogene; 2007 Feb; 26(8):1238-44. PubMed ID: 16909100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages.
    Fu SL; Lipsick JS
    Cell Growth Differ; 1997 Jan; 8(1):35-45. PubMed ID: 8993832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
    Nicot C; Mahieux R; Opavsky R; Cereseto A; Wolff L; Brady JN; Franchini G
    Oncogene; 2000 Apr; 19(17):2155-64. PubMed ID: 10815807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes differentially expressed in two types of v-myb-transformed avian myelomonocytic cells.
    Nakano T; Graf T
    Oncogene; 1992 Mar; 7(3):527-34. PubMed ID: 1549365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts.
    Smarda J; Fialová M; Smarda J
    Folia Biol (Praha); 2001; 47(1):11-3. PubMed ID: 11232863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.
    Dini PW; Eltman JT; Lipsick JS
    J Virol; 1995 Apr; 69(4):2515-24. PubMed ID: 7884901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.